Systemic Anti-Cancer Therapy in Synovial Sarcoma: A Systematic Review (Q58546977)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30388821%20AND%20SRC:MED&resulttype=core&format=json

1 May 2020

title

Systemic Anti-Cancer Therapy in Synovial Sarcoma: A Systematic Review (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30388821%20AND%20SRC:MED&resulttype=core&format=json

1 May 2020

1 reference

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30388821%20AND%20SRC:MED&resulttype=core&format=json

1 May 2020

Robin L Jones

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30388821%20AND%20SRC:MED&resulttype=core&format=json

1 May 2020

Juliette C Thompson

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30388821%20AND%20SRC:MED&resulttype=core&format=json

1 May 2020

Zaeem Khan

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30388821%20AND%20SRC:MED&resulttype=core&format=json

1 May 2020

author name string

Antoine Italiano

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30388821%20AND%20SRC:MED&resulttype=core&format=json

1 May 2020

Chet Bohac

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30388821%20AND%20SRC:MED&resulttype=core&format=json

1 May 2020

Kerstin Mueller

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30388821%20AND%20SRC:MED&resulttype=core&format=json

1 May 2020

Seth M Pollack

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30388821%20AND%20SRC:MED&resulttype=core&format=json

1 May 2020

Brian A Van Tine

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30388821%20AND%20SRC:MED&resulttype=core&format=json

1 May 2020

language of work or name

English

0 references

publication date

1 November 2018

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30388821%20AND%20SRC:MED&resulttype=core&format=json

1 May 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30388821%20AND%20SRC:MED&resulttype=core&format=json

1 May 2020

volume

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30388821%20AND%20SRC:MED&resulttype=core&format=json

1 May 2020

issue

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30388821%20AND%20SRC:MED&resulttype=core&format=json

Creative Commons Attribution 4.0 International

1 May 2020

copyright license

start time

1 November 2018

1 reference

April 2022 Public Data File from Crossref

copyright status

copyrighted

0 references

cites work

Synovial sarcoma. Uniform response of metastases to high dose ifosfamide

1 reference

12 December 2020

Synovial sarcoma: prognostic significance of tumor size, margin of resection, and mitotic activity for survival

1 reference

12 December 2020

Prognostic factors in localized primary synovial sarcoma: a multicenter study of 128 adult patients.

1 reference

12 December 2020

Fusions of the SYT and SSX genes in synovial sarcoma

1 reference

12 December 2020

Monophasic and biphasic synovial sarcomas abundantly express cancer/testis antigen NY-ESO-1 but not MAGE-A1 or CT7

1 reference

12 December 2020

Synovial sarcoma: the importance of size and location for survival

1 reference

12 December 2020

Prognostic factors associated with local recurrence, metastases, and tumor-related death in patients with synovial sarcoma

1 reference

12 December 2020

Synovial sarcoma: a retrospective analysis of 271 patients of all ages treated at a single institution

1 reference

12 December 2020

Histologic grade, but not SYT-SSX fusion type, is an important prognostic factor in patients with synovial sarcoma: a multicenter, retrospective analysis

1 reference

12 December 2020

Prognostic factors in advanced synovial sarcoma: an analysis of 104 patients treated at the Royal Marsden Hospital

1 reference

12 December 2020

Phase II trial of neoadjuvant vincristine, ifosfamide, and doxorubicin with granulocyte colony-stimulating factor support in children and adolescents with advanced-stage nonrhabdomyosarcomatous soft tissue sarcomas: a Pediatric Oncology Group Study

1 reference

12 December 2020

Grossly-resected synovial sarcoma treated by the German and Italian Pediatric Soft Tissue Sarcoma Cooperative Groups: discussion on the role of adjuvant therapies.

1 reference

12 December 2020

Directions in the immune targeting of cancer: lessons learned from the cancer-testis Ag NY-ESO-1.

1 reference

12 December 2020

NY-ESO-1: review of an immunogenic tumor antigen

1 reference

12 December 2020

Efficacy of trabectedin (ecteinascidin-743) in advanced pretreated myxoid liposarcomas: a retrospective study

1 reference

12 December 2020

Chemotherapy is associated with improved survival in adult patients with primary extremity synovial sarcoma

1 reference

12 December 2020

Prognostic implication of SYT-SSX fusion type in synovial sarcoma: a multi-institutional retrospective analysis in Japan

1 reference

12 December 2020

A phase II study of gefitinib for patients with advanced HER-1 expressing synovial sarcoma refractory to doxorubicin-containing regimens

1 reference

12 December 2020

A synovial sarcoma-specific preoperative nomogram supports a survival benefit to ifosfamide-based chemotherapy and improves risk stratification for patients

1 reference

12 December 2020

Neo/adjuvant chemotherapy does not improve outcome in resected primary synovial sarcoma: a study of the French Sarcoma Group.

1 reference

12 December 2020

Pazopanib, a multikinase angiogenesis inhibitor, in patients with relapsed or refractory advanced soft tissue sarcoma: a phase II study from the European organisation for research and treatment of cancer-soft tissue and bone sarcoma group (EORTC stu

1 reference

12 December 2020

Phase II multicenter trial of imatinib in 10 histologic subtypes of sarcoma using a bayesian hierarchical statistical model.

1 reference

12 December 2020

Synovial sarcoma: retrospective analysis of 250 patients treated at a single institution.

1 reference

12 December 2020

Efficacy and safety of trabectedin in patients with advanced or metastatic liposarcoma or leiomyosarcoma after failure of prior anthracyclines and ifosfamide: results of a randomized phase II study of two different schedules

1 reference

12 December 2020

Synovial sarcomas usually metastasize after >5 years: a multicenter retrospective analysis with minimum follow-up of 10 years for survivors.

1 reference

12 December 2020

Sparing strategy does not compromise prognosis in pediatric localized synovial sarcoma: experience of the International Society of Pediatric Oncology, Malignant Mesenchymal Tumors (SIOP-MMT) Working Group

1 reference

12 December 2020

Clinical features, treatment, and outcome in 102 adult and pediatric patients with localized high-grade synovial sarcoma.

1 reference

12 December 2020

Randomized phase II study comparing gemcitabine plus dacarbazine versus dacarbazine alone in patients with previously treated soft tissue sarcoma: a Spanish Group for Research on Sarcomas study.

1 reference

12 December 2020

Phase II clinical trial of neoadjuvant trabectedin in patients with advanced localized myxoid liposarcoma

1 reference

12 December 2020

Activity of eribulin mesylate in patients with soft-tissue sarcoma: a phase 2 study in four independent histological subtypes.

1 reference

12 December 2020

Long-term treatment outcomes for patients with synovial sarcoma: a 40-year experience at the University of Florida

1 reference

12 December 2020

Pazopanib for metastatic soft-tissue sarcoma (PALETTE): a randomised, double-blind, placebo-controlled phase 3 trial

1 reference

12 December 2020

An open-label, phase 2 study evaluating the efficacy and safety of the anti-IGF-1R antibody cixutumumab in patients with previously treated advanced or metastatic soft-tissue sarcoma or Ewing family of tumours.

1 reference

12 December 2020

Prognostic impact of the activation status of the Akt/mTOR pathway in synovial sarcoma.

1 reference

12 December 2020

Doxorubicin alone versus intensified doxorubicin plus ifosfamide for first-line treatment of advanced or metastatic soft-tissue sarcoma: a randomised controlled phase 3 trial.

1 reference

12 December 2020

Synovial sarcoma in children and adolescents.

1 reference

12 December 2020

A phase 2 trial of R1507, a monoclonal antibody to the insulin-like growth factor-1 receptor (IGF-1R), in patients with recurrent or refractory rhabdomyosarcoma, osteosarcoma, synovial sarcoma, and other soft tissue sarcomas: results of a Sarcoma Al

1 reference

12 December 2020

Epidemiology and survivorship of soft tissue sarcomas in adults: a national cancer database report

1 reference

12 December 2020

Soft tissue and visceral sarcomas: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

1 reference

12 December 2020

Synovial sarcoma: defining features and diagnostic evolution

1 reference

12 December 2020

Synovial sarcoma in children and adolescents: the European Pediatric Soft Tissue Sarcoma Study Group prospective trial (EpSSG NRSTS 2005).

1 reference

12 December 2020

Synovial sarcoma: recent discoveries as a roadmap to new avenues for therapy

1 reference

12 December 2020

Trabectedin in advanced synovial sarcomas: a multicenter retrospective study from four European institutions and the Italian Rare Cancer Network

1 reference

12 December 2020

Trabectedin monotherapy after standard chemotherapy versus best supportive care in patients with advanced, translocation-related sarcoma: a randomised, open-label, phase 2 study.

1 reference

12 December 2020

The PRISMA extension statement for reporting of systematic reviews incorporating network meta-analyses of health care interventions: checklist and explanations

1 reference

12 December 2020

Age as an independent prognostic factor for survival of localised synovial sarcoma patients

1 reference

12 December 2020

Gemcitabine-based chemotherapy in sarcomas: A systematic review of published trials.

1 reference

12 December 2020

Outcome of chemotherapy in advanced synovial sarcoma patients: Review of 15 clinical trials from the European Organisation for Research and Treatment of Cancer Soft Tissue and Bone Sarcoma Group; setting a new landmark for studies in this entity

1 reference

12 December 2020

Prognosis of T1 synovial sarcoma depends upon surgery by oncologic surgeons.

1 reference

12 December 2020

Olaratumab and doxorubicin versus doxorubicin alone for treatment of soft-tissue sarcoma: an open-label phase 1b and randomised phase 2 trial

1 reference

12 December 2020

Synovial Sarcoma Recurrence in Children and Young Adults

1 reference

12 December 2020

Safety and efficacy of regorafenib in patients with advanced soft tissue sarcoma (REGOSARC): a randomised, double-blind, placebo-controlled, phase 2 trial

1 reference

12 December 2020

Outcome and the effect of age and socioeconomic status in 1318 patients with synovial sarcoma in the English National Cancer Registry: 1985-2009.

1 reference

12 December 2020

Current classification, treatment options, and new perspectives in the management of adipocytic sarcomas

1 reference

12 December 2020

The importance of treating by histological subtype in advanced soft tissue sarcoma

1 reference

12 December 2020

Metastatic biomarkers in synovial sarcoma

1 reference

12 December 2020

Update on the role of trabectedin in the treatment of intractable soft tissue sarcomas

1 reference

12 December 2020

Patterns of care and outcomes of patients with METAstatic soft tissue SARComa in a real-life setting: the METASARC observational study

1 reference

12 December 2020

Histotype-tailored neoadjuvant chemotherapy versus standard chemotherapy in patients with high-risk soft-tissue sarcomas (ISG-STS 1001): an international, open-label, randomised, controlled, phase 3, multicentre trial

1 reference

12 December 2020

Histology and grading are important prognostic factors in synovial sarcoma

1 reference

12 December 2020

Adjuvant chemotherapy in resectable synovial sarcoma.

1 reference

12 December 2020

Neoadjuvant chemotherapy in soft tissue sarcomas: latest evidence and clinical implications.

1 reference

12 December 2020

Survival changes in Patients with Synovial Sarcoma, 1983-2012.

1 reference

12 December 2020

Activity of Eribulin in Patients With Advanced Liposarcoma Demonstrated in a Subgroup Analysis From a Randomized Phase III Study of Eribulin Versus Dacarbazine.

1 reference

12 December 2020

Olaratumab: PDGFR-α inhibition as a novel tool in the treatment of advanced soft tissue sarcomas

1 reference

12 December 2020

Pembrolizumab in advanced soft-tissue sarcoma and bone sarcoma (SARC028): a multicentre, two-cohort, single-arm, open-label, phase 2 trial

1 reference

12 December 2020

Synovial Sarcoma: Current Concepts and Future Perspectives

1 reference

12 December 2020

Epigenetic ConFUSION: SS18-SSX Fusion Rewires BAF Complex to Activate Bivalent Genes in Synovial Sarcoma

1 reference

12 December 2020

Identifiers

DOI

10.3390/CANCERS10110417

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30388821%20AND%20SRC:MED&resulttype=core&format=json

1 May 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30388821%20AND%20SRC:MED&resulttype=core&format=json

1 May 2020

PubMed publication ID

30388821

1 reference